Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-02 06:18 am Purchase | 2025-09-01 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ong Yee Lung | 872,000 20.760% | 654,000 (+300.00%) | Filing History |
| 2025-09-02 06:14 am Purchase | 2025-09-01 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Kua Khai Loon | 872,000 20.760% | 654,000 (+300.00%) | Filing History |
| 2025-09-02 06:09 am Purchase | 2025-09-01 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Yap Kim Choy | 872,000 20.760% | 654,000 (+300.00%) | Filing History |
| 2025-08-18 10:12 am Purchase | 2025-07-28 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Yap Kim Choy | 218,000 9.800% | 218,000 (New Position) | Filing History |
| 2025-08-18 10:10 am Purchase | 2025-07-28 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ong Yee Lung | 218,000 9.800% | 218,000 (New Position) | Filing History |
| 2025-08-18 10:08 am Purchase | 2025-07-28 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Kua Khai Loon | 218,000 9.800% | 218,000 (New Position) | Filing History |
| 2025-08-14 9:30 pm Unchanged | 2025-06-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-08 10:52 am Sale | 2025-08-05 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 0 0.000% | -129,629 (Position Closed) | Filing History |
| 2025-08-04 7:24 pm Sale | 2025-07-30 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 129,629 8.180% | -32,959 (-20.27%) | Filing History |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 1,656,315 9.200% | 1,652,808 (+47127.99%) | Filing History |
| 2025-03-04 10:32 am Purchase | 2025-02-26 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | Doris Wong Sing Ee | 810,953 70.000% | 810,953 (New Position) | Filing History |
| 2025-02-28 4:46 pm Purchase | 2025-02-06 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 162,588 15.840% | 162,588 (New Position) | Filing History |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 3,507 9.990% | 2,579 (+278.03%) | Filing History |
| 2024-11-14 7:21 pm Sale | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Lind Global Fund II LP | 0 0.000% | -426 (Position Closed) | Filing History |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 928 9.990% | 928 (New Position) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 8 0.180% | -206 (-96.30%) | Filing History |
| 2024-02-14 10:09 am Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 0 0.000% | -180 (Position Closed) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 809 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-07 5:03 pm Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES, L.P. | 0 0.000% | -782 (Position Closed) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 809 8.000% | 809 (New Position) | Filing History |